STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Altimmune (NASDAQ: ALT) announced that its management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference.

The session is scheduled for Wednesday, December 3, 2025 at 2:30 p.m. ET and will be available via webcast. Investors can access the webcast through the Events section of Altimmune's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

GAITHERSBURG, Md., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the Company’s management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference. Details are as follows:

Conference: Piper Sandler 37th Annual Healthcare Conference
Date/Time: Wednesday, December 3, 2025 at 2:30 p.m. ET

The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a glucagon/GLP-1 dual receptor agonist for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on X

Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Media Contact:
Savannah Valade
Real Chemistry
altimmune@realchemistry.com

This press release was published by a CLEAR® Verified individual.


FAQ

When will Altimmune (ALT) present at the Piper Sandler 37th Annual Healthcare Conference?

Altimmune will present on Wednesday, December 3, 2025 at 2:30 p.m. ET.

How can investors watch Altimmune (ALT) fireside chat on December 3, 2025?

The session will be webcast and can be accessed via the Events section of Altimmune's website.

What topics will Altimmune (ALT) management cover at the Piper Sandler conference?

Management will participate in a fireside chat to discuss recent developments and company outlook; the company did not list specific topics.

Where is the Piper Sandler 37th Annual Healthcare Conference presentation available after the live stream for Altimmune (ALT)?

Recordings are typically posted in the company's Events section; check Altimmune's website after the event.

Who from Altimmune (ALT) will attend the Piper Sandler conference?

The announcement states members of Altimmune's management team will participate; no individual names were provided.

Is there a cost to view Altimmune's (ALT) webcast at the Piper Sandler conference?

The company indicated the session will be webcast via its website; no cost or registration details were provided in the announcement.
Altimmune

NASDAQ:ALT

ALT Rankings

ALT Latest News

ALT Latest SEC Filings

ALT Stock Data

532.15M
103.60M
0.78%
43.32%
30.33%
Biotechnology
Pharmaceutical Preparations
Link
United States
GAITHERSBURG